Clinical Trials Directory

Trials / Completed

CompletedNCT01192672

Use of Expressive Writing in Irritable Bowel Syndrome (IBS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
197 (actual)
Sponsor
Boston University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test whether disease-related expressive writing is effective in the treatment of Irritable Bowel Syndrome (IBS).

Detailed description

Expressive writing involves writing about traumatic, stressful or emotional events. Expressive writing, for as little as 3-5 sessions of 20 minutes, has been found to improve both physical and psychological health based on health outcome measures such as number of doctor's visits and hospital days, blood pressure control, lung and immune function, and pain. Given its simplicity, and obvious advantages in terms of cost efficiency, expressive writing appears to have great potential as a therapeutic tool or as a means of self-help, either alone or as an adjunct to traditional therapies. This modality has not been studied in irritable bowel syndrome (IBS), a common gastrointestinal condition, which is lacking well-defined etiology or treatments and is best understood in a biopsychosocial context.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExpressive WritingSubjects in the Intervention were instructed to write for 30-minute intervals for 4 consecutive days about their deepest thoughts and feelings related to their Irritable Bowel Syndrome.
BEHAVIORALControl WritingSubjects were asked to write about the actions they performed during the last 24 hours. They were asked not to write about their feelings or thoughts related to these actions.

Timeline

Start date
2008-09-01
Primary completion
2010-09-01
Completion
2010-11-01
First posted
2010-09-01
Last updated
2017-03-15

Source: ClinicalTrials.gov record NCT01192672. Inclusion in this directory is not an endorsement.